Assessment of Changes in Body Composition After 3 Months of Dulaglutide Treatment

References

• Sun H, Saeedi P, Karuranga S, et al. IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabet Res Clin Pract. 2022;183:109119. doi:10.1016/j.diabres.2021.109119
   PubMed Web of Science ®Google Scholar
• De Marinis YZ, Salehi A, Ward CE, et al. GLP-1 inhibits and Adrenaline stimulates glucagon release by differential modulation of N- and L-type Ca2+ channel-dependent exocytosis. Cell Metab. 2010;11(6):543–553. doi:10.1016/j.cmet.2010.04.007
   Web of Science ®Google Scholar
• Li Y, Hansotia T, Yusta B, Ris F, Halban PA, Drucker DJ. Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis. J Biol Chem. 2003;278(1):471–478. doi:10.1074/jbc.M209423200
   PubMed Web of Science ®Google Scholar
• Yusta B, Baggio LL, Estall JL, et al. GLP-1 receptor activation improves beta cell function and survival following induction of endoplasmic reticulum stress. Cell Metab. 2006;4(5):391–406. doi:10.1016/j.cmet.2006.10.001
   PubMed Web of Science ®Google Scholar
• Meloni AR, DeYoung MB, Lowe C, Parkes DG. GLP-1 receptor activated insulin secretion from pancreatic β-cells: mechanism and glucose dependence. Diabetes Obes Metab. 2013;15(1):15–27. doi:10.1111/j.1463-1326.2012.01663.x
   PubMed Web of Science ®Google Scholar
• Flint A, Raben A, Ersbøll AK, Holst JJ, Astrup A. The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesity. Int J Obes Relat Metab Disord. 2001;25(6):781–792. doi:10.1038/sj.ijo.0801627
   PubMed Web of Science ®Google Scholar
• Wishart JM, Horowitz M, Morris HA, Jones KL, Nauck MA. Relation between gastric emptying of glucose and plasma concentrations of glucagon-like peptide-1. Peptides. 1998;19(6):1049–1053. doi:10.1016/S0196-9781(98)00052-7
   Web of Science ®Google Scholar
• Turton MD, O’Shea D, Gunn I, et al. A role for glucagon-like peptide-1 in the central regulation of feeding. Nature. 1996;379(6560):69–72. doi:10.1038/379069a0
   PubMed Web of Science ®Google Scholar
• Yu M, Benjamin MM, Srinivasan S, et al. Battle of GLP-1 delivery technologies. Adv Drug Deliv Rev. 2018;130:113–130. doi:10.1016/j.addr.2018.07.009
   PubMed Web of Science ®Google Scholar
• Hu S, Wang S, Qi C, et al. Cost-utility analysis of once-weekly semaglutide, dulaglutide, and exenatide for type 2 diabetes patients receiving metformin-based background therapy in China. Front Pharmacol. 2022;13:831364. doi:10.3389/fphar.2022.831364
   PubMed Web of Science ®Google Scholar
• Shi LX, Liu XM, Shi YQ, et al. Efficacy and safety of dulaglutide monotherapy compared with glimepiride in Chinese patients with type 2 diabetes: post-hoc analyses of a randomized, double-blind, Phase III study. J Diabetes Investig. 2020;11(1):142–150. doi:10.1111/jdi.13075
   Web of Science ®Google Scholar
• Li Y, Li L, De Peng Y, et al. Efficacy and safety of dulaglutide versus insulin glargine in Chinese T2DM patients: a subgroup analysis of a randomized trial (AWARD-CHN2). Diabetes Ther. 2019;10(4):1435–1452. doi:10.1007/s13300-019-0646-y
   Web of Science ®Google Scholar
• Gentilella R, Sesti G, Vazquez L, et al. Dulaglutide is an effective treatment for lowering HbA1c in patients with type 2 diabetes regardless of body mass index. Diabetes Obes Metab. 2019;21(12):2660–2666. doi:10.1111/dom.13853
   PubMed Web of Science ®Google Scholar
• Monami M, Dicembrini I, Nreu B, Andreozzi F, Sesti G, Mannucci E. Predictors of response to glucagon-like peptide-1 receptor agonists: a meta-analysis and systematic review of randomized controlled trials. Acta Diabetol. 2017;54(12):1101–1114. doi:10.1007/s00592-017-1054-2
   PubMed Web of Science ®Google Scholar
• Brunani A, Perna S, Soranna D, et al. Body composition assessment using bioelectrical impedance analysis (BIA) in a wide cohort of patients affected with mild to severe obesity. Clin Nutr. 2021;40(6):3973–3981. doi:10.1016/j.clnu.2021.04.033
   PubMed Web of Science ®Google Scholar
• Izzo A, Massimino E, Riccardi G, Della Pepa G. A narrative review on sarcopenia in type 2 diabetes mellitus: prevalence and associated factors. Nutrients. 2021;13(1):183. doi:10.3390/nu13010183
   PubMed Web of Science ®Google Scholar
• Mesinovic J, Zengin A, De Courten B, Ebeling PR, Scott D. Sarcopenia and type 2 diabetes mellitus: a bidirectional relationship. Diabetes Metab Syndr Obes. 2019;12:1057–1072. doi:10.2147/DMSO.S186600
   PubMed Web of Science ®Google Scholar
• Khin PP, Hong Y, Yeon M, Lee DH, Lee JH, Jun HS. Dulaglutide improves muscle function by attenuating inflammation through OPA-1-TLR-9 signaling in aged mice. Aging. 2021;13(18):21962–21974. doi:10.18632/aging.203546
   Google Scholar
• Piñar-Gutierrez A, García-Fontana C, García-Fontana B, Muñoz-Torres M. Obesity and bone health: a complex relationship. Int J Mol Sci. 2022;23(15):8303. doi:10.3390/ijms23158303
   Web of Science ®Google Scholar
• Villareal DT, Banks M, Siener C, Sinacore DR, Klein S. Physical frailty and body composition in obese elderly men and women. Obes Res. 2004;12(6):913–920. doi:10.1038/oby.2004.111
   PubMedGoogle Scholar
• Zhang YS, Weng WY, Xie BC, et al. Glucagon-like peptide-1 receptor agonists and fracture risk: a network meta-analysis of randomized clinical trials. Osteoporos Int. 2018;29(12):2639–2644. doi:10.1007/s00198-018-4649-8
   PubMed Web of Science ®Google Scholar
• Cheng L, Hu Y, Li YY, et al. Glucagon-like peptide-1 receptor agonists and risk of bone fracture in patients with type 2 diabetes: a meta-analysis of randomized controlled trials. Diabetes Metab Res Rev. 2019;35(7):e3168. doi:10.1002/dmrr.3168
   PubMed Web of Science ®Google Scholar
• Cai TT, Li HQ, Jiang LL, et al. Effects of GLP-1 receptor agonists on bone mineral density in patients with type 2 diabetes mellitus: a 52-week clinical study. Biomed Res Int. 2021;2021:3361309. doi:10.1155/2021/3361309
   Web of Science ®Google Scholar
• Plank LD. Dual-energy X-ray absorptiometry and body composition. Curr Opin Clin Nutr Metab Care. 2005;8(3):305–309. doi:10.1097/01.mco.0000165010.31826.3d
   Web of Science ®Google Scholar
• Ward LC. Segmental bioelectrical impedance analysis: an update. Curr Opin Clin Nutr Metab Care. 2012;15(5):424–429. doi:10.1097/MCO.0b013e328356b944
   PubMed Web of Science ®Google Scholar
• Lee LC, Hsu PS, Hsieh KC, et al. Standing 8-electrode bioelectrical impedance analysis as an alternative method to estimate visceral fat area and body fat mass in athletes. Int J Gen Med. 2021;14:539–548. doi:10.2147/IJGM.S281418
   PubMed Web of Science ®Google Scholar
• Enomoto M, Adachi H, Fukami A, et al. A useful tool as a medical checkup in a general population-bioelectrical impedance analysis. Front Cardiovasc Med. 2017;4:3. doi:10.3389/fcvm.2017.00003
   Web of Science ®Google Scholar
• Gómez-Hernández A, Beneit N, Díaz-Castroverde S, Escribano Ó. Differential role of adipose tissues in obesity and related metabolic and vascular complications. Int J Endocrinol. 2016;2016:1216783. doi:10.1155/2016/1216783
   Web of Science ®Google Scholar
• Umek N, Horvat S, Cvetko E. Skeletal muscle and fiber type-specific intramyocellular lipid accumulation in obese mice. Bosn J Basic Med Sci. 2021;21(6):730–738. doi:10.17305/bjbms.2021.5876
   Web of Science ®Google Scholar
• Wada S, Yasunaga Y, Oka K, et al. Submucosal fat accumulation in human colorectal tissue and its association with abdominal obesity and insulin resistance. United Eur Gastroenterol J. 2018;6(7):1065–1073. doi:10.1177/2050640618766926
   Web of Science ®Google Scholar
• Heni M, Eckstein SS, Schittenhelm J, et al. Ectopic fat accumulation in human astrocytes impairs insulin action. R Soc Open Sci. 2020;7(9):200701. doi:10.1098/rsos.200701
   Web of Science ®Google Scholar
• Frias JP, Bonora E, Nevarez Ruiz L, et al. Efficacy and safety of dulaglutide 3.0 mg and 4.5 mg versus dulaglutide 1.5 mg in metformin-treated patients with type 2 diabetes in a randomized controlled trial (AWARD-11). Diabetes Care. 2021;44(3):765–773. doi:10.2337/dc20-1473
   PubMed Web of Science ®Google Scholar